Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Page: 94
Published Date: 15 May 2025
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
Description 
Table of Contents 
Table of Figures 
Research Methodology 
Companies Mentioned 
Related Reports 
Product Tags
Table of Contents 
Table of Figures 
Research Methodology 
Companies Mentioned 
Related Reports 
Product Tags 
Description
According to our (Global Info Research) latest study, the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market size was valued at US$ 1488 million in 2024 and is forecast to a readjusted size of USD 2004 million by 2031 with a CAGR of 4.4% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Angiotensin II Type 1 Receptor (AT1R) Antagonists
According to our (Global Info Research) latest study, the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market size was valued at US$ 1488 million in 2024 and is forecast to a readjusted size of USD 2004 million by 2031 with a CAGR of 4.4% during review period.
Unit: US$ M
www.globalinforesearch.com
Business Risk & Industry Analysis Reports
AT1R antagonists are compounds that block the binding of angiotensin II to the Angiotensin II receptor 1 (AT1), thereby inhibiting the biological effects of angiotensin II. They are primarily used in the treatment of hypertension and heart failure.
This report is a detailed and comprehensive analysis for global Angiotensin II Type 1 Receptor (AT1R) Antagonists market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Angiotensin II Type 1 Receptor (AT1R) Antagonists market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Angiotensin II Type 1 Receptor (AT1R) Antagonists market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Angiotensin II Type 1 Receptor (AT1R) Antagonists market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Angiotensin II Type 1 Receptor (AT1R) Antagonists market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Angiotensin II Type 1 Receptor (AT1R) Antagonists
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi SA, Novartis, Merck, Aurobindo Pharma Ltd., Takeda Pharmaceutical Co., Ltd., Cosette Pharmaceuticals, Inc., AbbVie, Inc., Shenzhen Salubris Pharmaceuticals Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Angiotensin II Type 1 Receptor (AT1R) Antagonists market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
5mg
10mg
20mg
50mg
80mg
100mg
150mg
400mg
Market segment by Application
Hospital
Clinic
Others
Major players covered
Sanofi SA
Novartis
Merck
Aurobindo Pharma Ltd.
Takeda Pharmaceutical Co., Ltd.
Cosette Pharmaceuticals, Inc.
AbbVie, Inc.
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Angiotensin II Type 1 Receptor (AT1R) Antagonists product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists, with price, sales quantity, revenue, and global market share of Angiotensin II Type 1 Receptor (AT1R) Antagonists from 2020 to 2025.
Chapter 3, the Angiotensin II Type 1 Receptor (AT1R) Antagonists competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Angiotensin II Type 1 Receptor (AT1R) Antagonists breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Angiotensin II Type 1 Receptor (AT1R) Antagonists market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Angiotensin II Type 1 Receptor (AT1R) Antagonists.
Chapter 14 and 15, to describe Angiotensin II Type 1 Receptor (AT1R) Antagonists sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 5mg
1.3.3 10mg
1.3.4 20mg
1.3.5 50mg
1.3.6 80mg
1.3.7 100mg
1.3.8 150mg
1.3.9 400mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size & Forecast
1.5.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity (2020-2031)
1.5.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price (2020-2031)
2.1 Sanofi SA
2.1.1 Sanofi SA Details
2.1.2 Sanofi SA Major Business
2.1.3 Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
2.1.4 Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Sanofi SA Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
2.2.4 Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Novartis Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
2.3.4 Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck Recent Developments/Updates
2.4 Aurobindo Pharma Ltd.
2.4.1 Aurobindo Pharma Ltd. Details
2.4.2 Aurobindo Pharma Ltd. Major Business
2.4.3 Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
2.4.4 Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Aurobindo Pharma Ltd. Recent Developments/Updates
2.5 Takeda Pharmaceutical Co., Ltd.
2.5.1 Takeda Pharmaceutical Co., Ltd. Details
2.5.2 Takeda Pharmaceutical Co., Ltd. Major Business
2.5.3 Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
2.5.4 Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Takeda Pharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Cosette Pharmaceuticals, Inc.
2.6.1 Cosette Pharmaceuticals, Inc. Details
2.6.2 Cosette Pharmaceuticals, Inc. Major Business
2.6.3 Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
2.6.4 Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Cosette Pharmaceuticals, Inc. Recent Developments/Updates
2.7 AbbVie, Inc.
2.7.1 AbbVie, Inc. Details
2.7.2 AbbVie, Inc. Major Business
2.7.3 AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
2.7.4 AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 AbbVie, Inc. Recent Developments/Updates
2.8 Shenzhen Salubris Pharmaceuticals Co., Ltd.
2.8.1 Shenzhen Salubris Pharmaceuticals Co., Ltd. Details
2.8.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. Major Business
2.8.3 Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
2.8.4 Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments/Updates
3.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Manufacturer (2020-2025)
3.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Manufacturer (2020-2025)
3.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Angiotensin II Type 1 Receptor (AT1R) Antagonists by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturer Market Share in 2024
3.4.3 Top 6 Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturer Market Share in 2024
3.5 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Overall Company Footprint Analysis
3.5.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Region Footprint
3.5.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Company Product Type Footprint
3.5.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Region
4.1.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Region (2020-2031)
4.1.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Region (2020-2031)
4.1.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Region (2020-2031)
4.2 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031)
4.3 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031)
4.4 Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031)
4.5 South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031)
4.6 Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031)
5.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2031)
5.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Type (2020-2031)
5.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Type (2020-2031)
6.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2031)
6.2 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Application (2020-2031)
6.3 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Application (2020-2031)
7.1 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2031)
7.2 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2031)
7.3 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country
7.3.1 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2020-2031)
7.3.2 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8.1 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2031)
8.2 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2031)
8.3 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country
8.3.1 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2020-2031)
8.3.2 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9.1 Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Region
9.3.1 Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10.1 South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2031)
10.2 South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2031)
10.3 South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country
10.3.1 South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2020-2031)
10.3.2 South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11.1 Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size by Country
11.3.1 Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Drivers
12.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Restraints
12.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Angiotensin II Type 1 Receptor (AT1R) Antagonists and Key Manufacturers
13.2 Manufacturing Costs Percentage of Angiotensin II Type 1 Receptor (AT1R) Antagonists
13.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Typical Distributors
14.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables Table 1. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Type, (USD Million), 2020 & 2024 & 2031 Table 2. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Application, (USD Million), 2020 & 2024 & 2031 Table 3. Sanofi SA Basic Information, Manufacturing Base and Competitors Table 4. Sanofi SA Major Business Table 5. Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services Table 6. Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 7. Sanofi SA Recent Developments/Updates Table 8. Novartis Basic Information, Manufacturing Base and Competitors Table 9. Novartis Major Business Table 10. Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services Table 11. Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 12. Novartis Recent Developments/Updates Table 13. Merck Basic Information, Manufacturing Base and Competitors Table 14. Merck Major Business Table 15. Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services Table 16. Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 17. Merck Recent Developments/Updates Table 18. Aurobindo Pharma Ltd. Basic Information, Manufacturing Base and Competitors Table 19. Aurobindo Pharma Ltd. Major Business Table 20. Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services Table 21. Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 22. Aurobindo Pharma Ltd. Recent Developments/Updates Table 23. Takeda Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors Table 24. Takeda Pharmaceutical Co., Ltd. Major Business Table 25. Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services Table 26. Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 27. Takeda Pharmaceutical Co., Ltd. Recent Developments/Updates Table 28. Cosette Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors Table 29. Cosette Pharmaceuticals, Inc. Major Business Table 30. Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services Table 31. Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 32. Cosette Pharmaceuticals, Inc. Recent Developments/Updates Table 33. AbbVie, Inc. Basic Information, Manufacturing Base and Competitors Table 34. AbbVie, Inc. Major Business Table 35. AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services Table 36. AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 37. AbbVie, Inc. Recent Developments/Updates Table 38. Shenzhen Salubris Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors Table 39. Shenzhen Salubris Pharmaceuticals Co., Ltd. Major Business Table 40. Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services Table 41. Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025) Table 42. Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments/Updates Table 43. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Manufacturer (2020-2025) & (K Units) Table 44. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Manufacturer (2020-2025) & (USD Million) Table 45. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Manufacturer (2020-2025) & (US$/Unit) Table 46. Market Position of Manufacturers in Angiotensin II Type 1 Receptor (AT1R) Antagonists, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024 Table 47. Head Office and Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Site of Key Manufacturer Table 48. Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Company Product Type Footprint Table 49. Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Company Product Application Footprint Table 50. Angiotensin II Type 1 Receptor (AT1R) Antagonists New Market Entrants and Barriers to Market Entry Table 51. Angiotensin II Type 1 Receptor (AT1R) Antagonists Mergers, Acquisition, Agreements, and Collaborations Table 52. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR Table 53. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Region (2020-2025) & (K Units) Table 54. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Region (2026-2031) & (K Units) Table 55. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Region (2020-2025) & (USD Million) Table 56. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Region (2026-2031) & (USD Million) Table 57. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Region (2020-2025) & (US$/Unit) Table 58. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Region (2026-2031) & (US$/Unit) Table 59. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2025) & (K Units) Table 60. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2026-2031) & (K Units) Table 61. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Type (2020-2025) & (USD Million) Table 62. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Type (2026-2031) & (USD Million) Table 63. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Type (2020-2025) & (US$/Unit) Table 64. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Type (2026-2031) & (US$/Unit) Table 65. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2025) & (K Units) Table 66. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2026-2031) & (K Units) Table 67. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Application (2020-2025) & (USD Million) Table 68. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Application (2026-2031) & (USD Million) Table 69. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Application (2020-2025) & (US$/Unit) Table 70. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Application (2026-2031) & (US$/Unit) Table 71. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2025) & (K Units) Table 72. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2026-2031) & (K Units) Table 73. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2025) & (K Units) Table 74. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2026-2031) & (K Units) Table 75. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2020-2025) & (K Units) Table 76. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2026-2031) & (K Units) Table 77. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2020-2025) & (USD Million) Table 78. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2026-2031) & (USD Million) Table 79. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2025) & (K Units) Table 80. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2026-2031) & (K Units) Table 81. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2025) & (K Units) Table 82. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2026-2031) & (K Units) Table 83. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2020-2025) & (K Units) Table 84. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2026-2031) & (K Units) Table 85. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2020-2025) & (USD Million) Table 86. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2026-2031) & (USD Million) Table 87. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2025) & (K Units) Table 88. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2026-2031) & (K Units) Table 89. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2025) & (K Units) Table 90. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2026-2031) & (K Units) Table 91. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Region (2020-2025) & (K Units) Table 92. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Region (2026-2031) & (K Units) Table 93. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Region (2020-2025) & (USD Million) Table 94. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Region (2026-2031) & (USD Million) Table 95. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2025) & (K Units) Table 96. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2026-2031) & (K Units) Table 97. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2025) & (K Units) Table 98. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2026-2031) & (K Units) Table 99. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2020-2025) & (K Units) Table 100. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2026-2031) & (K Units) Table 101. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2020-2025) & (USD Million) Table 102. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2026-2031) & (USD Million) Table 103. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2020-2025) & (K Units) Table 104. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Type (2026-2031) & (K Units) Table 105. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2020-2025) & (K Units) Table 106. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Application (2026-2031) & (K Units) Table 107. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2020-2025) & (K Units) Table 108. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity by Country (2026-2031) & (K Units) Table 109. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2020-2025) & (USD Million) Table 110. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Country (2026-2031) & (USD Million) Table 111. Angiotensin II Type 1 Receptor (AT1R) Antagonists Raw Material Table 112. Key Manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists Raw Materials Table 113. Angiotensin II Type 1 Receptor (AT1R) Antagonists Typical Distributors Table 114. Angiotensin II Type 1 Receptor (AT1R) Antagonists Typical Customers List of Figures Figure 1. Angiotensin II Type 1 Receptor (AT1R) Antagonists Picture Figure 2. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue by Type, (USD Million), 2020 & 2024 & 2031 Figure 3. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Type in 2024 Figure 4. 5mg Examples Figure 5. 10mg Examples Figure 6. 20mg Examples Figure 7. 50mg Examples Figure 8. 80mg Examples Figure 9. 100mg Examples Figure 10. 150mg Examples Figure 11. 400mg Examples Figure 12. 150mg Examples Figure 13. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value by Application, (USD Million), 2020 & 2024 & 2031 Figure 14. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application in 2024 Figure 15. Hospital Examples Figure 16. Clinic Examples Figure 17. Others Examples Figure 18. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value, (USD Million): 2020 & 2024 & 2031 Figure 19. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value and Forecast (2020-2031) & (USD Million) Figure 20. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity (2020-2031) & (K Units) Figure 21. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Price (2020-2031) & (US$/Unit) Figure 22. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Manufacturer in 2024 Figure 23. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Manufacturer in 2024 Figure 24. Producer Shipments of Angiotensin II Type 1 Receptor (AT1R) Antagonists by Manufacturer Sales ($MM) and Market Share (%): 2024 Figure 25. Top 3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturer (Revenue) Market Share in 2024 Figure 26. Top 6 Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturer (Revenue) Market Share in 2024 Figure 27. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Region (2020-2031) Figure 28. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value Market Share by Region (2020-2031) Figure 29. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 30. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 31. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 32. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 33. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 34. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Type (2020-2031) Figure 35. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value Market Share by Type (2020-2031) Figure 36. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Type (2020-2031) & (US$/Unit) Figure 37. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Application (2020-2031) Figure 38. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Revenue Market Share by Application (2020-2031) Figure 39. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Application (2020-2031) & (US$/Unit) Figure 40. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Type (2020-2031) Figure 41. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Application (2020-2031) Figure 42. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Country (2020-2031) Figure 43. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value Market Share by Country (2020-2031) Figure 44. United States Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 45. Canada Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 46. Mexico Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 47. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Type (2020-2031) Figure 48. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Application (2020-2031) Figure 49. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Country (2020-2031) Figure 50. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value Market Share by Country (2020-2031) Figure 51. Germany Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 52. France Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 53. United Kingdom Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 54. Russia Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 55. Italy Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 56. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Type (2020-2031) Figure 57. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Application (2020-2031) Figure 58. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Region (2020-2031) Figure 59. Asia-Pacific Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value Market Share by Region (2020-2031) Figure 60. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 61. Japan Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 62. South Korea Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 63. India Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 64. Southeast Asia Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 65. Australia Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 66. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Type (2020-2031) Figure 67. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Application (2020-2031) Figure 68. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Country (2020-2031) Figure 69. South America Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value Market Share by Country (2020-2031) Figure 70. Brazil Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 71. Argentina Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 72. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Type (2020-2031) Figure 73. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Application (2020-2031) Figure 74. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Quantity Market Share by Country (2020-2031) Figure 75. Middle East & Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value Market Share by Country (2020-2031) Figure 76. Turkey Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 77. Egypt Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 78. Saudi Arabia Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 79. South Africa Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Value (2020-2031) & (USD Million) Figure 80. Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Drivers Figure 81. Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Restraints Figure 82. Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Trends Figure 83. Porters Five Forces Analysis Figure 84. Manufacturing Cost Structure Analysis of Angiotensin II Type 1 Receptor (AT1R) Antagonists in 2024 Figure 85. Manufacturing Process Analysis of Angiotensin II Type 1 Receptor (AT1R) Antagonists Figure 86. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industrial Chain Figure 87. Sales Channel: Direct to End-User vs Distributors Figure 88. Direct Channel Pros & Cons Figure 89. Indirect Channel Pros & Cons Figure 90. Methodology Figure 91. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.
Validation and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi SA Novartis Merck Aurobindo Pharma Ltd. Takeda Pharmaceutical Co., Ltd. Cosette Pharmaceuticals, Inc. AbbVie, Inc. Shenzhen Salubris Pharmaceuticals Co., Ltd.
Related Reports
7 Dec 2024
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
- Digging deeper into global industry information and providing market strategies.Contact Us >>
